Navigation Links
New Options Available for the 13 Million Men Who Suffer from Testosterone Deficiency

Although female hormone replacement has been the center of attention, male hormone levels are just as important to health and wellness. More men are getting tested and more treatment options are becoming available.

Dallas, TX (PRWEB) September 1, 2009 -- While all the news over the last decade seems to revolve around female hormones, more physicians are seeing the need to test and treat their male patients for testosterone deficiency. A new study suggests that as many as 13 million men may suffer from a deficiency of testosterone. Some physicians feel that the findings are consistent with more men asking for help. "The stigma associated with asking for help is gone. Some of this may be due to the increased drug advertisements targeted for men," states Dr. Anderson, MD of Executive Medicine of Texas

Testosterone deficiency is a serious problem and not only is associated with sexual dysfunction, but can also cause loss of muscle mass, weight gain, higher cholesterol levels, cardiovascular disease and other disorders. Patients with low testosterone levels may feel sluggish or depressed. Personal relationships can suffer too, due to the patient's lack of enthusiasm or interest.

Testosterone creams and injections have been in the mainstream of health care treatments and available to patients in the past. The good news is that the FDA announced the approval of the first long-acting Testosterone replacement treatment. Testopel® is manufactured by Slate Pharmaceuticals and is administered by a growing number of physicians. It consists of small pellets that are inserted under the skin just below the beltline during an in-office procedure. The procedure lasts only a few minutes and is done without sedation or stitches.

"Our patients are thrilled that we can do this procedure and they don't have to think about it again for up to six months." Walter Gaman, MD of Executive Medicine of Texas continues, "Since we are always looking for proven treatments to better help our patients, Testopel® is a welcome addition."

Dr. Gaman was one of the first physicians to offer this treatment within his practice, after it became FDA approved this year. The procedure is quick and easy, but does take a skilled physician to administer. Physicians administering the pellets should be properly instructed on administration and appropriate prescribing.

Executive Medicine of Texas is a leading provider in men's health and wellness. They treat executives and high profile individuals from around the globe and now offer Testopel® as an in-office procedure. The cost per insertion is $1200, which includes a three month testosterone blood level. Insertions can last up to six months, but blood tests can check to ensure that levels are remaining adequate, whereas small number of patients may metabolize the hormone faster requiring insertions to be repeated before the six month mark.

To schedule testing for testosterone deficiency or if you have documented deficiency and wish to schedule a Testopel® insertion, call (817) 552-4300 or (800) 910-EXEC. To learn more about Executive Medicine of Texas, visit To learn more about Testopel®, visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Georgia Reproductive Specialists Free Infertility Seminar: Fertility Options 101
2. ValueOptions(R) Awards Coordination of Benefits and Overpayment Services Contract to HMS
3. Blue Cross and Blue Shield Association Introduces Interactive Navigation Solution That Helps Individuals and Families Find Healthcare Coverage Options
4. Commercial Real Estate Group of Tucson Unveils Online Tool that Quickly Informs Commercial Real Estate Tenants of Lease Options
5. FREE INFERTILITY SEMINAR: Fertility Options 101
6. ValueOptions Wins Maryland Mental Health Contract
7. Pennsylvanians With Disabilities Call for an End to Institution-Only Options
8. TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM)
9. Health Insurance Options for Domestic Partnerships
10. 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer
11. Hybrid Concierge Medical Practice Provides More Value, Options to Growing Number of Physicians Nationwide
Post Your Comments:
Related Image:
New Options Available for the 13 Million Men Who Suffer from Testosterone Deficiency
(Date:12/1/2015)... ... December 02, 2015 , ... The National Association of ... into its VIP Woman of the Year Circle. She is recognized with this ... exclusively for professional women, boasting 850,000 members and, over 200 operating Local Chapters. ...
(Date:12/1/2015)... D.C. (PRWEB) , ... December 01, 2015 , ... ... updated, comprehensive website detailing the important role that meat and poultry play ... in meat and poultry, a nutrition quiz where visitors can check their “meat ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated Rental Services (“Integrated ... Industries International, LLC (“JII”). , With support from JII, Integrated Rental is poised ... hospitals, surgery centers, clinics, research labs and medical facilities across the United States. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one of the ... bottle has won top honors in Beverage World Magazine’s Global Packaging Design Awards, taking ... it has been selected as a 2015 U.S.A. Taste Champion in the American Masters ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... we have seen vast improvements in scientific research and discoveries, leading us to ... increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, ... and Pipeline Analysis - Global Forecast to 2020", published by ... USD 73,529.2 Million by 2020 from USD 40,281.6 Million in ... Browse 37 market data ...
(Date:12/1/2015)... BANGALORE, India and PITTSBURGH ... TASE: MYL) today announced that it expects to be ... developing country markets funded by international donors, TLE400 (Tenofovir ... Efavirenz 400 mg) for $99 per patient, per year. ... to develop TLE400. The significantly reduced price could generate ...
(Date:12/1/2015)... , Dec. 1, 2015  AccuTEC Blades, a ... new corporate logo and brand identity program. The ... and engineering of bladed products where "the edge ... --> Serving manufacturers and distributors ... auto glass equipment, AccuTEC,s product lines include those ...
Breaking Medicine Technology: